Trial intelligence / Profile preview

Ibuprofen injection for postoperative moderate to severe pain

CTR20170426Phase 3Completed

Sponsor
Hainan Zhengrui Pharmaceutical Technology Development
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibuprofen in postoperative pain, sponsored by Hainan Zhengrui Pharmaceutical Technology Development. Started May 2017; status: completed.

02

Drugs

ibuprofen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20170426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call